Microvitality

Microvitality

United StatesUnited States
Pre-SeedFounded 2024Updated 1 month ago
Bio Tech/Life SciencesHealthtechDigital healthHealth and wellness3D PrintingDeep TechB2BB2C1-5 employees
First-Time FounderFirst-Time FounderFemale FounderFemale FounderImmigrant FounderImmigrant FounderActively Raising

About

Microbiome-powered diagnostics company developing an ingestible sampling capsule for non-invasive, accurate small intestine microbiome profiling to diagnose gastrointestinal conditions like SIBO, IBS, and Celiac Disease.

Traction & Metrics

Users & Clients

2

Clients

Fundraising

$75K

Previous Round

Team

Sofia

Sofia

COO

Zoe

Zoe

CEO

Yash Mandloi

Yash Mandloi

Finance Intern

Products

Microvitality Ingestible Sampling Capsule

Microvitality is pioneering a non-invasive diagnostic platform that enables direct sampling of the small intestine, addressing a critical blind spot in gastrointestinal disease diagnosis and precision medicine. Despite the microbiome’s central role in digestion, immunity, drug absorption, and systemic health, the small intestine remains largely inaccessible, forcing clinicians to rely on indirect or invasive diagnostics that fail to capture its true biology. Microvitality’s ingestible capsule autonomously collects uncontaminated small-intestine fluid, generating high-quality biological data that current methods cannot access. The platform is initially applied to Small Intestine Bacterial Overgrowth (SIBO), a severely underdiagnosed condition, and is designed to scale across additional gastrointestinal indications including Irritable Bowel Syndrome (IBS) and Celiac Disease, creating a durable platform opportunity in microbiome-driven precision diagnostics.

Click to read more